Related Experiment Video
Updated: Apr 18, 2026
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Targeting Galectin-1 in pancreatic cancer: immune surveillance on guard
Neus Martínez-Bosch1, Pilar Navarro1
1Cancer Research Program; IMIM (Hospital del Mar Medical Research Institute) ; Barcelona, Spain.
Abstract:
The tumor microenviroment and immune barrier are known to modulate malignant disease progression. We have recently identified Galectin-1 as a key player in a novel stromal regulatory reaction driving immune evasion in pancreatic tumors in vivo. These results suggest that Galectin-1 inhibition represents a potential therapeutic strategy for one of the most deadly types of cancer.
Insights
Galectin-1 is a key factor in pancreatic tumors evading the immune system. Inhibiting Galectin-1 may offer a new therapeutic approach for this deadly cancer.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor microenvironment and immune barriers significantly influence cancer progression.
- Immune evasion is a critical mechanism utilized by malignant tumors.
Purpose of the Study:
- To investigate the role of Galectin-1 in pancreatic tumor immune evasion.
- To explore Galectin-1 inhibition as a potential therapeutic strategy for pancreatic cancer.
Main Methods:
- In vivo studies of pancreatic tumors.
- Identification of key molecular players in stromal regulatory reactions.
Main Results:
- Galectin-1 was identified as a crucial mediator in a stromal reaction.
- This reaction drives immune evasion within pancreatic tumors.
- Galectin-1 plays a key role in the tumor microenvironment's modulation of immune responses.
Conclusions:
- Galectin-1 is implicated in pancreatic cancer immune evasion.
- Targeting Galectin-1 presents a promising therapeutic avenue for pancreatic cancer treatment.
More Related Videos
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015